Login to Your Account

Financings Roundup

Tuesday, November 15, 2011
• Lexicon Pharmaceuticals Inc., of The Woodlands, Texas, said it is planning a $163 million rights offering in which shareholders would receive nontransferable subscription rights to purchase up to 144.2 million shares of common stock.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription